Judge: David S. Cunningham, Case: 19STCV22935, Date: 2025-05-06 Tentative Ruling
Case Number: 19STCV22935 Hearing Date: May 6, 2025 Dept: 11
JUUL (JCCP 5052)
Tentative Ruling Re: Motion to Quash Re: Jurisdiction
Date: 5/6/25
Time: 11:00
am
Moving Party: Altria
Group, Inc., et al. (collectively “Altria” or “Altria Defendants”)
Opposing Party: Blake Arruda, Frank Dedmon, Dominick
Zimmerman, Tariq Hassan, Maximillian Samike, Benjamin Hayt, Garrett Challburg,
and Joseph Siravo (collectively “Plaintiffs”)
Department: 11
Judge: David
S. Cunningham III
________________________________________________________________________
TENTATIVE RULING
Altria’s motion to quash is granted as to Plaintiffs Blake Arruda, Frank
Dedmon, Dominick Zimmerman, and Tariq Hassan.
The hearing is continued as to Plaintiffs Maximillian Samike, Benjamin
Hayt, Garrett Challburg, and Joseph Siravo.
BACKGROUND
This case concerns e-cigarettes manufactured by JUUL Labs,
Inc. (“JLI”).
Here, Altria moves to quash
service of process, claiming the Court lacks jurisdiction over Plaintiffs’
claims.[1]
LAW
There are “two types of personal
jurisdiction[,]” general and specific. (Bristol-Myers
Squibb Co. v. Superior Court of California, San Francisco County (2017) 582
U.S. 255, 262 (“BMS”).)
“A state court may
exercise general jurisdiction only when a defendant is
‘essentially at home’ in the State. [Citation.]” (Preciado v. Freightliner Custom Chassis
Corp. (2023) 87 Cal.App.5th 964, 976.) “General jurisdiction,
as its name implies, extends to ‘any and all claims’ brought against a
defendant. [Citation.]” (Ibid.) “Those claims need not relate to the forum
State or the defendant's activity there; they may concern events and conduct
anywhere in the world.” (Ibid.) “But that breadth imposes a correlative limit:
Only a select ‘set of affiliations with a forum’ will expose a defendant to
such sweeping jurisdiction. [Citation.]”
(Ibid.) “In what [the Supreme
Court] ha[s] called the ‘paradigm’ case, an individual is subject
to general jurisdiction in her place of domicile. [Citation.]” (Ibid.) “And the ‘equivalent’ forums for a corporation
are its place of incorporation and principal place of business.” (Ibid.)
“When
determining whether specific jurisdiction exists, courts consider the
‘relationship among the defendant, the forum, and the litigation.’” (Halyard Health, Inc. v. Kimberly-Clark Corp. (2019) 43 Cal.App.5th 1062,
1070.) “[C]ourts focus on the nature and
quality (not the quantity) of defendant’s activity in the forum state.” (Edmond & Karnow, Cal. Practice Guide:
Civ. Procedure Before Trial (The Rutter Group June 2023 Update) ¶ 3:240.) “[S]ingle
or occasional acts of the corporate agent in a state” may be adequate as long
as the lawsuit relates to the “in-state activity.” (Daimler AG v. Bauman (2014) 571 U.S. 117,
127 (“Daimler”); see also Edmond & Karnow, supra, at ¶ 3:240.1 [“Provided a
‘substantial connection’ with the forum is created thereby, even a single act
may support specific personal jurisdiction over a nonresident.”].)
To exercise
specific jurisdiction, a court must find purposeful availment (the defendant made
purposeful contacts with the forum), relatedness (the litigation arises from or
relates to the defendant’s forum contacts), and reasonableness (the forum’s “assertion”
of specific jurisdiction “comport[s] with ‘fair play and substantial justice’”).
(Halyard Health, supra,
43 Cal.App.4th at 1070.)
Plaintiff bears the initial burden to
establish general jurisdiction and/or specific jurisdiction. (See Vons
Companies, Inc. v. Seabest Foods, Inc. (1996) 14 Cal.4th 434,
449.)
DISCUSSION
Preliminary Matters
The Court incorporates the July 29, 2022
ruling granting Altria’s motion to quash and the October 18, 2022 ruling
denying reconsideration. Those rulings
stand, and the Court declines to reanalyze the evidence that was included in
those records (the Court will only consider new evidence). (See Kouba Reply Decl., Ex. MM [attaching
chart that lists exhibits submitted by Plaintiffs that were and were not part
of the prior records].)
The Court also declines to follow the federal
court’s April 29, 2022 summary-judgment decision because:
* it is nonbinding;
* it predates the Court’s July 29th
and October 18th rulings by months;
* the discussion of personal jurisdiction is
brief (see Haberman Decl., Ex. 1, pp. 15-17 [devoting two, double-spaced pages
to personal jurisdiction]);
* the record appears to have been different
(almost none of the evidence that this Court analyzed is cited) (see ibid.);
and
* the summary-judgment standard – requiring
all reasonable inferences to be drawn in the plaintiff’s favor – is different
than the motion-to-quash standard. (See,
e.g., Reply, pp. 10-11.)
General Jurisdiction
General jurisdiction is unsatisfied. Each Altria Defendant is incorporated and
headquartered in Virginia. (See Motion,
p. 3.)
Specific Jurisdiction
Purposeful-Availment Prong
This prong is uncontested.
Relatedness Prong
Arruda, Dedmon, Zimmerman,
and Hassan
The July 29th ruling
contains an extensive discussion of BMS.
The Court continues to believe that “the motivation for granting review
in BMS was to rein in the California courts’ expansive take on specific
jurisdiction, especially application of the ‘sliding scale approach.’” (7/29/22 Statement of Decision, p. 10.”) The High Court was “focus[ed] on where the
nonresidents obtained, ingested, and suffered injury from Plavix.” (Ibid.)
“It is apparent that the majority wanted to send a message – generally limiting
the available forums for specific jurisdiction to the states where the
nonresidents encountered the product and were harmed by it – to avoid future
lower court rulings ‘resembl[ing] a loose and spurious form of general
jurisdiction.’” (Ibid. [quoting BMS].) Indeed, “[a]t its core, the decision appears
to form a general rule barring the exercise of specific jurisdiction against an
out-of-state defendant if the out-of-state plaintiff buys the product outside
the forum, uses it outside the forum, and is harmed by it outside the
forum[.]” (Ibid.)
Ford Motor Company v. Montana
Eighth Judicial District Court (2021) 592 U.S. 351 (“Ford”) “is
congruent.” (Ibid.) “In footnote 3, the Supreme Court rejects the
notion that ‘a California court could hear a claim against Ford brought by an
Ohio plaintiff based on an accident occurring in Ohio involving a car purchased
in Ohio.’” (Ibid. [quoting Ford];
cf. Ford, supra, 592 U.S. at 1027-1028 [stating that Daimler
provides “an illustration – even a paradigm example – of how specific
jurisdiction works”: “A California court would exercise specific
jurisdiction ‘if a California plaintiff, injured in a California accident
involving a Daimler-manufactured vehicle, sued Daimler [in that court] alleging
that the vehicle was defectively designed’”], italics and bolding added.)
The October 18th
ruling discusses Daimler Trucks North America, LLC v. Superior Court
(2022) 80 Cal.App.5th 946 (“Daimler Trucks”). The Court of Appeal found jurisdiction
present there because:
* the . . . plaintiffs were California
residents [citation];
* Daimler manufactured and marketed
Freightliner Cascadia trucks for “intercontinental long haul[s]” and “sold the
California market on trips that emanate from California to other states and
back” [citation];
* the plaintiff’s employer purchased the
subject truck in California [citation];
*
the plaintiff drove the truck in California, “as the outbound leg of his travel
that resulted in his injuries began in California” [citation]; [and]
*
the plaintiffs “sought damages for loss of consortium and injuries treated in
California” [citations].
(10/18/22 Reconsideration
Ruling, pp. 8-9.)
Given these rules, the Court
finds that Plaintiffs fail to meet their burden. It is undisputed that these Plaintiffs reside
outside California, purchased their JLI products outside California, used their
JLI products outside California, and suffered their alleged injuries outside
California. (See, e.g., Motion, pp.
7-8.) None of them alleges purchase or
use inside the state. (See ibid.)
Plaintiffs’ new evidence does not
change the result. The key point is that these Plaintiffs’ purchases, uses, and
injuries happened in other states.
Plaintiffs fail to cite any new evidence that shows that Altria
participated in distributing JLI products from California “to Plaintiffs’
states and purchase locations[.]”
(7/29/22 Statement of Decision, p. 15.)
Consequently, the motion to quash
is granted.
Samike, Hayt, Challburg,
and Siravo
Samike, Hayt, Challburg, and
Siravo have declared under oath that they purchased and/or used JLI products in
California. (See, e.g., Motion, pp.
14-15 [conceding this fact].)
Altria contends the Court should
ignore the declarations because they are inconsistent with Plaintiffs’ fact
sheets and complaints. (See id. at p.
15.)
Altria also states:
None of these
individuals alleges that they first used JUUL in California, became addicted to
JUUL in California, resided in California during the their alleged JUUL
purchases, or incurred damages in California.
[Citation.] Furthermore, without
information on when, where, and why a Plaintiff purchased JUUL in California,
it is impossible to conclude that Plaintiff’s claim arises out of or relates to
any action Altria took in or directed at California. The Altria Defendants have never been the
only provider of distribution and retail services to JLI. To the contrary, they are alleged to have
provided only limited services, for little over a year, at only certain
locations. [Citation.] The overwhelming majority of JUUL products
thus were distributed, purchased, and consumed without any involvement by the
Altria Defendants.
(Ibid.)
Plaintiffs disagree. They contend the deposition testimonies of
Samike, Hayt, Challburg, and Siravo corroborate the declarations. (See Opposition, pp. 28-29.)
On balance, the current record is
inadequate. For the most part, the cited
deposition excerpts are not attached to Plaintiffs’ counsel’s declaration. (See Opposition, p. 29; see also Haberman
Decl., Ex. 74 [attaching page 473 instead of pages 476 and 477], Ex. 76
[attaching page 141 instead of pages 371 and 372], Ex. 77 [attaching pages 437
and 438 instead of pages 481 and 482].)
The exception is Hayt’s deposition testimony. His excerpt states that he bought JLI
products in California in either 2019 or 2020 and that he may be able to get
information from his bank that shows the purchases. (See Haberman Decl., Ex. 75, p. 393.) However, Plaintiffs fail to cite the specific
date and location of the purchase, so the Court cannot tell whether the
purchase relates to Altria’s California contacts. (See Reply, p. 12; see also Kouba Reply
Decl., Ex. T, pp. 5185785795-5185785796 [attaching amendment to services
contract between JLI and Altria, which indicates that the contractual
relationship existed between December 20, 2018 through March 31, 2020]; Jayone
Foods, Inc. v. Aekyung Industrial Co. Ltd. (2019) 31 Cal.App.5th
543, 562-563 [reversing grant of motion to quash because “Plaintiffs [] presented
evidence showing that a nonresident defendant contracted with a California
distributor to ship its product to California, and the California distributor
in turn sold the product to a California store, where Plaintiffs’ mother, a
California resident, repeatedly purchased the product”].) The same is true of Samike’s, Challburg’s,
and Siravo’s excerpts. Samike testified
that, on one occasion, he bought JLI products from an unidentified gas station
in Long Beach, California. (See Kouba
Reply Decl., Ex. KK, p. 481.)[2] Challburg “assume[d]” that he bought and used
JLI products while on spring break in California in 2018. (See id. at Ex. JJ, p. 370.) Siravo said he used JLI products in
California during a trip sometime “between 2020 and 2021, 2022[.]” (Id. at Ex. II, p. 480.) These statements seem too vague to
demonstrate the requisite connection to Altria’s forum contacts and to satisfy
Plaintiffs’ burden.
The Court finds that the hearing
should be continued to give Plaintiffs a chance to supplement the record.[3]
[4]
[1]
Earlier in the litigation, Altria brought a motion to quash against 10 exemplar
claimants who reside out of state. The
Court granted that motion on July 29, 2022 and denied reconsideration on
October 18, 2022. (See, e.g., Motion,
pp. 5-6 [summarizing procedural history].)
[2]
Altria claims the purchase took place in 2019.
(See Reply, p. 11.)
[3] As a matter of guidance, I tend to disagree with
Altria’s argument regarding addiction and injury dates. In theory, even if an addiction or injury
first arises out of state, a subsequent related contact in California could
contribute to the addiction or injury or could cause a new injury.
[4]
“The Altria Defendants’ burden to show that it would be unreasonable to
exercise jurisdiction does not apply unless and until Plaintiffs satisfy the
‘relatedness’ prong.” (7/29/22 Statement
of Decision, p. 19.)
JCCP 5052 (JUUL Labs Product Cases)
Tentative Ruling Re: Motion to Seal No. 3
Date: 5/6/25
Time: 11:00
am
Moving Party: Altria Group, Inc., et al.
(collectively “Altria”)
Opposing Party: None
Department: 11
Judge: David S. Cunningham III
________________________________________________________________________
TENTATIVE RULING
Altria’s motion to
seal no. 1 is denied without prejudice.
BACKGROUND
This case concerns e-cigarettes manufactured by JUUL Labs,
Inc.
Here, Altria moves to seal
certain exhibits filed in connection with the opposition to Altria’s motion to
quash for lack of personal jurisdiction.
LAW
The court may order that a record be filed under seal only if
it expressly finds facts that establish:
(1)
There exists an
overriding interest that overcomes the right of public access to the record;
(2)
The overriding
interest supports sealing the record;
(3)
A substantial
probability exists that the overriding interest will be prejudiced if the
record is not sealed;
(4)
The proposed sealing
is narrowly tailored; and
(5)
No less restrictive
means exist to achieve the overriding interest.
(Cal. Rules of Court, rule
2.550(d).) “These findings embody constitutional requirements for a request to seal court records,
protecting the First Amendment right of public access[.]” (Edmon & Karnow, Cal. Practice Guide: Civ. Procedure
Before Trial (The Rutter Group June 2023 Update) ¶ 9:418, emphasis in
original.)[1]
DISCUSSION
Altria moves to seal two groups
of documents. The first group consists
of Plaintiffs’ fact sheets (exhibits D, F, H, J, L, N, P, and R to the
declaration of David Kouba).[2] The second group consists of Plaintiffs’
declarations (exhibits E, G, I, K, M, O, Q, S, and T).
The motion is denied without
prejudice. Altria seeks a blanket
sealing order. The standard rule in
California, however, is that “[o]nly the specific
words of documents that constitute the sensitive material should be sealed[.]” (Edmon & Karnow, supra, at ¶
9:418.5.) “[G]enerally, it is not
permissible to seal the entire document.”
(Ibid.)
Altria
is free to refile to seal specific confidential information – e.g., Social
Security numbers, medical data, drug histories, and addresses.
[1] The parties’ agreement to
seal documents is not enough to support a motion to seal. (Id. at ¶ 9:417.1 [“Parties sometimes operate
under an informal arrangement pursuant to which documents are ‘deemed filed
under seal’ unless an objection is made.
Such an arrangement ‘is entirely inconsistent with the mandatory
requirements of rules 2.550 and 2.551 and the constitutional values informing
those requirements.’”].)
[2]
“Plaintiffs” are Blake Arruda, et al.
JCCP 5052 (JUUL Labs Product Cases)
Tentative Ruling Re: Motion to Seal No. 2
Date: 5/6/25
Time: 11:00
am
Moving Party: Altria Group, Inc., et al.
(collectively “Altria”)
Opposing Party: None
Department: 11
Judge: David S. Cunningham III
________________________________________________________________________
TENTATIVE RULING
Altria’s motion to
seal no. 2 is:
* denied as to reply
pages 6:12-14, 6:18-28, 10:14-28, and 11:1-15; and
* denied without prejudice as to
exhibits Z, AA, BB, CC, DD, EE, II, and LL.
BACKGROUND
This case concerns e-cigarettes manufactured by JUUL Labs,
Inc.
Here, Altria moves to seal
certain exhibits filed in connection with the reply to Altria’s motion to quash
for lack of personal jurisdiction.
LAW
The court may order that a record be filed under seal only if
it expressly finds facts that establish:
(1)
There exists an
overriding interest that overcomes the right of public access to the record;
(2)
The overriding
interest supports sealing the record;
(3)
A substantial
probability exists that the overriding interest will be prejudiced if the
record is not sealed;
(4)
The proposed sealing
is narrowly tailored; and
(5)
No less restrictive
means exist to achieve the overriding interest.
(Cal. Rules of Court, rule
2.550(d).) “These findings embody constitutional requirements for a request to seal court records,
protecting the First Amendment right of public access[.]” (Edmon & Karnow, Cal. Practice Guide: Civ. Procedure
Before Trial (The Rutter Group June 2023 Update) ¶ 9:418, emphasis in
original.)[1]
DISCUSSION
Altria moves to seal three groups
of documents. The first group consists of
pages in Altria’s reply to the motion to quash (pages 6:12-14, 6:18-28, 10:14-28,
and 11:1-15). The second group consists
of excerpts from the depositions of other Defendants’ executives,
representatives, and/or employees (exhibits Z, AA, BB, CC, DD, and EE to the
reply declaration of David Kouba). The
third group consists of excerpts from the depositions of Plaintiffs Joseph Siravo
and Benjamin Hayt (exhibits II and LL).
The motion is denied as to the
reply pages. Pages 6:12-14, 6:18-28,
10:14-28, and 11:1-15 mostly contain legal arguments. The information does not appear to be private,
sensitive, and/or confidential.
The remainder of the motion is
denied without prejudice. Altria seeks a
blanket sealing order. The standard rule
in California, however, is that “[o]nly the
specific words of documents that constitute the sensitive material should be
sealed[.]” (Edmon & Karnow, supra,
at ¶ 9:418.5.) “[G]enerally, it is not
permissible to seal the entire document.”
(Ibid.)
Altria
is free to refile to seal specific words, sentences, paragraphs, and pages that
disclose private, sensitive, and/or confidential information.
[1] The parties’ agreement to
seal documents is not enough to support a motion to seal. (Id. at ¶ 9:417.1 [“Parties sometimes operate
under an informal arrangement pursuant to which documents are ‘deemed filed
under seal’ unless an objection is made.
Such an arrangement ‘is entirely inconsistent with the mandatory
requirements of rules 2.550 and 2.551 and the constitutional values informing
those requirements.’”].)
JCCP 5052 (JUUL Labs Product Cases)
Tentative Ruling Re: Motion to Seal No. 3
Date: 5/6/25
Time: 11:00
am
Moving Party: Altria Group, Inc., et al.
(collectively “Altria”)
Opposing Party: None
Department: 11
Judge: David S. Cunningham III
________________________________________________________________________
TENTATIVE RULING
Altria’s motion to seal no. 3 is granted, except the motion is denied without
prejudice as to exhibits 11, 26, 33, 35, and 42.
BACKGROUND
This case concerns e-cigarettes manufactured by JUUL Labs,
Inc.
Here, Altria moves to seal
certain exhibits filed in connection with the opposition to Altria’s motion to
quash for lack of personal jurisdiction.
LAW
The court may order that a record be filed under seal only if
it expressly finds facts that establish:
(1)
There exists an
overriding interest that overcomes the right of public access to the record;
(2)
The overriding
interest supports sealing the record;
(3)
A substantial
probability exists that the overriding interest will be prejudiced if the
record is not sealed;
(4)
The proposed sealing
is narrowly tailored; and
(5)
No less restrictive
means exist to achieve the overriding interest.
(Cal. Rules of Court, rule
2.550(d).) “These findings embody constitutional requirements for a request to seal court records,
protecting the First Amendment right of public access[.]” (Edmon & Karnow, Cal. Practice Guide: Civ. Procedure
Before Trial (The Rutter Group June 2023 Update) ¶ 9:418, emphasis in
original.)[1]
DISCUSSION
Altria moves to seal two groups
of documents. The first group consists
of pages in Plaintiffs’ opposition brief (pages 4:12-13, 5:6-9, 5:19-23, 6:5-6,
6:10-21, 6:23-28, 7:2-3, 7:8-12, 7:19-21, 8:24-26, 8:28, 9:1-6, 9:21-23,
10:1-5, 10:18-28, 11:1-28, 12-1:28, 13:1-18, 13:21-28, 14, 15, 16:4-5).[2] The second group consists of exhibits
(exhibits 11, 16, 20, 22-26, 28, 31, 33, 35, 42, 47-48, 51, 54-69, 71-73).
The motion is granted as to the
first group. The statements on these
pages come from documents that have been marked “Confidential” or “Highly
Confidential” under the protective order.
The statements reveal strategies, negotiations, and other sensitive
business information. At this stage of
the litigation, there is an overriding interest in keeping this information confidential. The overriding interest supports sealing the
pages. There is a substantial
probability that the overriding interest will be harmed absent sealing. The sealing is narrowly tailored. And there is no less restrictive means to
protect the overriding interest.
With a few exceptions, the motion
is also granted as to the second group. Many
of the exhibits constitute internal business documents that, like the opposition
pages, reveal strategies, negotiations, and other sensitive business
information. The Court finds the rule
2.550(d) requirements satisfied.
The exceptions are exhibits 11,
26, 33, 35, and 42, which are emails.
While some confidential information may be included, a significant
amount appears to be nonconfidential. A
blanket sealing order is inappropriate, so this portion of the motion is denied
without prejudice.
Altria
is free to refile to seal specific confidential information contained in
exhibits 11, 26, 33, 35, and 42.
[1] The parties’ agreement to
seal documents is not enough to support a motion to seal. (Id. at ¶ 9:417.1 [“Parties sometimes operate
under an informal arrangement pursuant to which documents are ‘deemed filed
under seal’ unless an objection is made.
Such an arrangement ‘is entirely inconsistent with the mandatory
requirements of rules 2.550 and 2.551 and the constitutional values informing
those requirements.’”].)
[2]
“Plaintiffs” are Blake Arruda, et al.
************************************************************************************************
SUPERIOR COURT OF THE
STATE OF CALIFORNIA
FOR THE COUNTY OF LOS
ANGELES
The Court, having reviewed the
moving papers, opposition, and reply, and considered the arguments presented,
issues the following Order consistent with its Tentative Ruling.
I.
BACKGROUND
This
case concerns e-cigarettes manufactured by JUUL Labs, Inc. (“JLI”). The Altria
Defendants (Altria Group, Inc., Philip Morris USA Inc., Altria Client Services
LLC, Altria Group Distribution Company, and Altria Enterprises LLC) have moved
to quash service of process for lack of personal jurisdiction over the claims
of eight specific Plaintiffs: Blake Arruda, Dominick Zimmerman, Frank Dedmon,
Tariq Hassan, Maximillian Samike, Joseph Siravo, Benjamin Hayt, and Garrett
Challburg. These Plaintiffs are collectively referred to as the
"Non-California Opt-Out Plaintiffs".
The
Altria Defendants are not California corporations and are not subject to
general jurisdiction in California. (Daimler AG v. Bauman, 571
U.S. 117 (2014).) General jurisdiction typically
exists where a corporation has its formal place of incorporation or principal
place of business, which for the Altria Defendants is Virginia. (Id.)
The Court has previously found that only specific jurisdiction is at issue
here.
To
establish personal jurisdiction over a defendant, a plaintiff must plead facts
sufficient to demonstrate general or specific jurisdiction. (Bristol-Myers
Squibb Co. v. Superior Court, 137 S. Ct. 1773 (2017).) When jurisdiction is challenged, the plaintiff bears
the burden of proof by a preponderance of the evidence to establish a basis for
jurisdiction, supporting jurisdictional allegations with affidavits and other
authenticated documents. (See In re
Automobile Antitrust Cases I & II (2005) 135 Cal.App.4th 100, 110.)
The
Altria Defendants previously moved to quash service of process for lack of
personal jurisdiction with respect to ten out-of-state exemplar plaintiffs in
this JCCP. On July 29, 2022, the Court issued a Statement of Decision granting
that motion, finding the exemplar plaintiffs failed to show specific personal
jurisdiction over the Altria Defendants. The Court explained that its ruling
applied only to the exemplar plaintiffs. However, the Altria Defendants contend
that the same legal principles and largely the same factual record apply to the
Non-California Opt-Out Plaintiffs.
Specific jurisdiction requires that a plaintiff’s
claims “arise[] out of or relate[] to the defendant’s contacts with the forum”.
(Ranza v. Nike, Inc., 793 F.3d 1059, 1068 (9th Cir. 2015) (quotations
omitted); Briskin v. Shopify, Inc., 87 F.4th 404, 411 (9th Cir. 2023)
(similar). This requirement is “more
than a guarantee of immunity from inconvenient or distant litigation”—it is
based on due process. Bristol-Myers,
137 S. Ct. at 1780 (citation and quotations omitted); see also Burger King
Corp. v. Rudzewicz, 471 U.S. 462, 475 (1985) (“The Due Process Clause
protects an individual’s liberty interest in not being subject to the binding
judgments of a forum with which he has established no meaningful ‘contacts,
ties, or relations.’”) (citation and quotation omitted).
II.
DISCUSSION
The
Altria Defendants argue that the Non-California Opt-Out Plaintiffs cannot
establish specific personal jurisdiction because their claims do not arise out
of or relate to Altria's contacts with California. Altria relies heavily on the
U.S. Supreme Court decisions in Bristol-Myers Squibb Co. v. Superior
Court, 137 S. Ct. 1773 (2017) ("BMS")
and Ford Motor Co. v. Montana Eighth Judicial District Court, 141
S. Ct. 1017 (2021) ("Ford").
In BMS,
the Supreme Court held that nonresident plaintiffs could not establish specific
jurisdiction in California because they did not purchase, ingest, or suffer
injury from the product in California. The Court noted that the connection
between the nonresidents' claims and the forum was weak because they were not
California residents and did not claim harm in California. BMS appears
to form a general rule barring specific jurisdiction against an out-of-state
defendant if the out-of-state plaintiff buys, uses, and is harmed by the
product outside the forum.
In Ford,
the Court ruled that specific jurisdiction could be based on the defendant’s
forum-directed actions even if those actions did not directly cause the
specific injuries, but emphasized that the plaintiffs were residents of the
forum states, used the products there, and suffered injuries there. The Ford court
distinguished a scenario like the present one, noting that a California court
would likely not have specific jurisdiction over a claim against Ford brought
by an Ohio plaintiff based on an accident and car purchased in Ohio. Ford is
congruent with BMS in this regard.
The
California Court of Appeal decision in Daimler Trucks North America,
LLC v. Superior Court of Los Angeles County, 571 U.S. 117 (2014).) (Daimler Trucks) is also relevant. This Court
previously noted that Daimler Trucks applied the principles
of Ford and BMS. In Daimler Trucks,
the court found jurisdiction present where the plaintiffs were California
residents, the product was marketed and purchased in California, and the
plaintiff drove the truck and sought damages for injuries treated in
California, despite the accident occurring out of state. These were considered
important distinctions from BMS.
The
Altria Defendants' relationship with JLI, a California corporation at the time,
is a central focus of Plaintiffs' argument for jurisdiction. However, Altria
contends that these contacts, such as investment activities, due diligence,
negotiations, and service agreements, are unrelated to Plaintiffs' tort claims
and cannot serve as a basis for specific jurisdiction, citing cases like Rivelli
v. Hemm, 67 Cal. App. 5th 380 (2021). Altria also argues that any services
provided to JLI under the December 20, 2018 Services Agreement, such as retail
distribution and shelf-space services, regulatory services related to JLI's
PMTA, and marketing assistance, would, for out-of-state plaintiffs, relate to
services directed at the plaintiffs' home jurisdictions, not California.
Plaintiffs
counter that Altria actively directed and controlled JLI and that specific
jurisdiction is appropriate because the underlying controversy arises out of or
relates to Altria's contacts with JLI within California. Plaintiffs allege a
"symbiotic relationship" where Altria sought to influence and control
JLI before and after its investment. They cite meetings and communications in
California, Altria's goal to direct JLI's activities, assistance with
distribution, regulatory engagement, and brand building, seeking
"significant ownership and influence" and "Altria approval"
for JLI's plans, assisting with regulatory matters, including efforts related
to mint flavoring, providing distribution and retail services, providing
research and testing services, and direct marketing efforts. Plaintiffs argue
that a significant amount of the liability producing conduct occurred in
California through Altria's joint participation with California-based JLI.
Plaintiffs also raise a theory of conspiracy jurisdiction.
This
Court has previously considered and rejected many of the arguments and evidence
presented by Plaintiffs. Specifically, the Court found Altria's investment
activities and due diligence insufficient to establish jurisdiction, Altria's
retail and distribution services did not support jurisdiction over claims by
out-of-state plaintiffs, PMTA services were primarily based in Virginia and
Washington, D.C., and marketing evidence did not show Altria's control or that
plaintiffs saw the advertisements. The Court also previously rejected the
notion of derivative liability, joint venture, or partnership absent sufficient
evidence of control. Plaintiffs' current submissions, even the additional
exhibits, largely reiterate evidence and arguments previously considered and
found insufficient.
The
Court also declines to follow the MDL court's April 29, 2022 summary judgment
order as binding precedent, noting it is nonbinding, predates this Court's
prior rulings, is brief, may have involved a different record, and applied a
summary judgment standard requiring inferences in favor of the plaintiff, which
is different from the motion to quash standard.
III.
RULING
A.
Granting Motion to Quash as to Plaintiffs Arruda, Dedmon, Zimmerman, and
Hassan:
Plaintiffs
Blake Arruda, Frank Dedmon, Dominick Zimmerman, and Tariq Hassan do not reside
in California and do not claim to have suffered injuries or damages in
California. Based on their allegations and disclosures, there is little to
nothing that would connect these four Plaintiffs and their JUUL-related claims
against Altria to California. Four of the Non-California Opt-Out Plaintiffs do
not allege any California connection at all, not claiming to have ever bought
or used JUUL in California. These Plaintiffs are non-residents bringing claims
based on transactions, acts, omissions, injuries, and damages that occurred
entirely out-of-state. Mr. Arruda, for example, is a Connecticut resident who
began using JUUL and claims injury in 2016 while residing in Rhode Island and
Connecticut, and he claims purchases in Connecticut and Rhode Island, not
California. The Altria Defendants contend that for these four Plaintiffs who
have never been to California, personal jurisdiction is plainly lacking. Their
claims would arise out of and relate to conduct in the state where they lived,
purchased, were injured, and incurred damages.
As
in BMS, these four Plaintiffs did not purchase JUUL in California,
did not ingest JUUL products in California, and were not injured by JUUL in
California. This Court previously concluded that ten out-of-state exemplar
plaintiffs with similar allegations and claims could not establish specific
jurisdiction over the Altria Defendants, agreeing that BMS and Ford support
a general rule barring specific jurisdiction in such circumstances. This
conclusion applies with equal force to Plaintiffs Arruda, Dedmon, Zimmerman,
and Hassan. Their claims against Altria do not arise out of or relate to
Altria’s California contacts. While Altria had contacts with California, such
as through communications, negotiations, and investment in JLI, these
Plaintiffs' tort claims do not arise out of or relate to those activities. Even
if services were provided by Altria related to JUUL, for these Plaintiffs,
those services would relate to services directed at their home jurisdictions,
not California.
Therefore, the motion to quash service of process
should be granted as to Plaintiffs Blake Arruda, Frank Dedmon, Dominick
Zimmerman, and Tariq Hassan.
B. Continuing Hearing as to Plaintiffs
Samike, Hayt, Challburg, and Siravo:
For
the other four Non-California Opt-Out Plaintiffs—Maximillian Samike, Benjamin
Hayt, Garrett Challburg, and Joseph Siravo—the situation differs slightly. Like
the others, they reside outside of California and do not claim to have ever
lived in the State, nor do they claim purchases, marketing exposure, injury, or
damages in California. However, they claim to have used or purchased JUUL in
California on some isolated occasions. Plaintiffs argue that these claims
distinguish them from the exemplar plaintiffs and the other opt-out plaintiffs,
clearing the threshold for specific jurisdiction under this Court's prior
ruling and BMS.
The
Altria Defendants acknowledge these claims but argue they are generic, vague,
and inconsistent with other statements made by these Plaintiffs in their
Plaintiff Fact Sheets and complaints. For example, some Plaintiffs did not
identify California purchases in their fact sheets or complaints. Altria
contends that even isolated use or purchase in California, without more details
connecting it to Altria's California contacts, is insufficient to establish
specific jurisdiction, particularly since Plaintiffs do not allege they first
used, became addicted, resided, or incurred damages in California, and Altria's
services to JLI were limited in scope and duration.
The
Court has reviewed the deposition testimony cited by Plaintiffs regarding their
California use or purchase. While the testimony and declarations broadly
identify purchases and/or uses in California, they often lack specific details
about when, where, and why the purchase or use occurred. Without specific dates
and locations, it is difficult to conclude that the purchase or use relates to
any action Altria took in or directed at California. For example, Mr. Siravo
testified to using a vapor product in California after summer 2020, possibly
JUUL, but Altria was no longer providing services by then, and his alleged
injury occurred prior to 2020. Mr. Samike mentions a purchase at an
unidentified gas station in Long Beach, California. Mr. Challburg "assume[s]"
he used/bought JUUL in California in 2018. Mr. Siravo used JUUL in California
between 2020 and 2022.
The
Court finds that the statements regarding California purchases and/or uses by
Plaintiffs Samike, Hayt, Challburg, and Siravo are currently too vague to
definitively demonstrate the requisite connection to Altria’s forum contacts
and meet Plaintiffs’ burden at this stage. However, rather than denying the
motion outright as to these Plaintiffs, the Court finds it appropriate to allow
for further clarification of the factual record. The Court tends to disagree
with Altria's argument that an addiction or injury arising out-of-state
necessarily precludes jurisdiction if subsequent related contacts in California
contributed to the injury.
Therefore,
the hearing should be continued as to Plaintiffs Maximillian Samike, Benjamin
Hayt, Garrett Challburg, and Joseph Siravo to allow Plaintiffs an opportunity
to supplement the record with more specific details regarding their alleged
purchases and/or uses of JUUL products in California and to allow Altria to
conduct jurisdictional discovery if necessary.
ORDER
IT
IS HEREBY ORDERED that Altria
Group, Inc.'s, et al., motion to quash service of process is GRANTED as
to Plaintiffs Blake Arruda, Frank Dedmon, Dominick Zimmerman, and Tariq Hassan
for lack of personal jurisdiction.
IT
IS FURTHER ORDERED that the
hearing on Altria Group, Inc.'s, et al., motion to quash service of process
is CONTINUED as to Plaintiffs Maximillian Samike, Benjamin
Hayt, Garrett Challburg, and Joseph Siravo. The Court will set a new hearing
date and potentially a schedule for supplemental briefing or jurisdictional
discovery regarding the specific details of these Plaintiffs' alleged JUUL
purchases and/or uses in California and their connection to Altria's California
contacts.
IT IS SO ORDERED.
DATED: ______________________________________________ THE
HONORABLE DAVID S. CUNNINGHAM III